Autonomic Regulation Trial (ART)

This study has been completed.
Sponsor:
Information provided by:
Deutsches Herzzentrum Muenchen
ClinicalTrials.gov Identifier:
NCT00196274
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted

September 13, 2005
September 13, 2005
May 2000
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Autonomic Regulation Trial (ART)
Autonomic Regulation Trial (ART)

The purpose of this study was to develope and evaluate a new method for risk stratification which predicts high mortality risk in patients with cardiac disease based on simultateous examination of high resolution ECG, continuous arterial pressure and a breathing signal.

Not Provided
Observational
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Infarction, Myocardial
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1000
Not Provided
Not Provided

Inclusion Criteria:

acute myocardial infarction, presence of sinus rhythm

Exclusion Criteria:

diseases (other than acute myocardial infarction) with impact on prognosis

Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00196274
GE IDE No. R00500, BMBF13N7705/2
Not Provided
Not Provided
Deutsches Herzzentrum Muenchen
Not Provided
Study Chair: Georg Schmidt, MD Deutsches Herzzentrum Muenchen
Study Director: Petra Barthel, MD Deutsches Herzzentrum Muenchen
Principal Investigator: Axel Bauer, MD Deutsches Herzzentrum Muenchen
Deutsches Herzzentrum Muenchen
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP